share_log

南京医药第九届董事会2023年度独立董事述职报告(陆银娣)

2023 Independent Director Debriefing Report of the 9th Board of Directors of Nanjing Pharmaceutical (Lu Yindi)

SZSI ·  Apr 8

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.